![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2019
Anzahl der Publikationen: 2
2019
Fabbro, Michel; Moore, Kathleen N.; Dorum, Anne; Tinker, Anna; Mahner, Sven; Bover, Isabel; Banerjee, Susana; Tognon, Germana; Goffin, Frederic; Shapira-Frommer, Ronnie; Wenham, Robert M.; Hellman, Kristina; Provencher, Diane; Harter, Philipp; Palacio Vazquez, Isabel; Follana, Philippe; Pineda, Mario J.; Mirza, Mansoor R.; Hazard, Sebastien J. und Matulonis, Ursula A.
(2019):
Efficacy and safety of niraparib as maintenance treatment in older patients (>= 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial.
In: Gynecologic Oncology, Bd. 152, Nr. 3: S. 560-567
Matulonis, Ursula A.; Walder, Lydia; Nottrup, Trine J.; Bessette, Paul; Mahner, Sven; Gil-Martin, Marta; Kalbacher, Elsa; Ledermann, Jonathan A.; Wenham, Robert M.; Woie, Kathrine; Lau, Susie; Marme, Frederik; Casado Herraez, Antonio; Hardy-Bessard, Anne-Claire; Banerjee, Susana; Lindahl, Gabriel; Benigno, Benedict; Buscema, Joseph; Travers, Karin; Guy, Holly und Mirza, Mansoor R.
(2019):
Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial.
In: Journal of Clinical Oncology, Bd. 37, Nr. 34: S. 3183-3191